Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KRYS

Krystal Biotech Inc

Apr 28 • 04:00PM ET

269.27

-3.48 -1.28 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN BIIB REGN VRTX BMRN INCY NBIX SRPT AXSM QURE

| Held by: IJR VTI VB IWM XBI VBK FBT VXF SPSM IJT

Scroll to Statements

Index	RUT	P/E	39.34	EPS (ttm)	6.84	Insider Own	13.09%	Shs Outstand	29.19M	Perf Week	-1.24%
Market Cap	7.93B	Forward P/E	28.56	EPS next Y	9.43	Insider Trans	-6.19%	Shs Float	25.58M	Perf Month	9.73%
Enterprise Value	7.11B	PEG	1.18	EPS next Q	1.49	Inst Own	95.11%	Short Float	11.39%	Perf Quarter	-2.92%
Income	204.83M	P/S	20.37	EPS this Y	10.30%	Inst Trans	-1.59%	Short Ratio	10.36	Perf Half Y	44.67%
Sales	389.13M	P/B	6.45	EPS next Y	24.98%	ROA	17.14%	Short Interest	2.91M	Perf YTD	9.22%
Book/sh	41.78	P/C	9.58	EPS next 5Y	24.14%	ROE	18.91%	52W High	298.30 -9.73%	Perf Year	58.65%
Cash/sh	28.12	P/FCF	41.96	EPS past 3/5Y	- -	ROIC	16.69%	52W Low	122.80 119.28%	Perf 3Y	220.56%
Dividend Est.	-	EV/EBITDA	42.39	Sales past 3/5Y	- -	Gross Margin	92.50%	Volatility	4.22% 3.53%	Perf 5Y	229.10%
Dividend TTM	-	EV/Sales	18.27	EPS Y/Y TTM	127.79%	Oper. Margin	41.41%	ATR (14)	9.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.56	Sales Y/Y TTM	33.95%	Profit Margin	52.64%	RSI (14)	53.12	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	9.95	EPS Q/Q	11.65%	SMA20	0.90%	Beta	0.52	Target Price	325.78
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	17.52%	SMA50	2.49%	Rel Volume	0.50	Prev Close	272.75
Employees	295	LT Debt/Eq	0.01	Earnings	May 04 BMO	SMA200	24.64%	Avg Volume	281.10K	Price	269.27
IPO	Sep 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.08% 1.67%	Trades		Volume	142,585	Change	-1.28%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)